Registering a CAGR of 3.5% over the forecast period, the Heparin market is anticipated to reach the market value of US$ 1221.5 million in the year 2027 from US$ 1063.4 million in the year 2021.
Heparin is a glycosaminoglycan that occurs naturally in the body. Heparin is an anticoagulant that is used in medicine to prevent blood clots from forming. It is used to treat unstable angina and heart attacks in particular. Heparin is also used to treat deep vein thrombosis, acute coronary syndrome, atrial fibrillation, and pulmonary embolism, as well as hemofiltration during cardiac surgery and cardiopulmonary bypass. The rising prevalence of chronic diseases such as cancer, heart disease, stroke, diabetes, and arthritis would improve global market statistics. According to the Centers for Disease Control (CDC), roughly 659,000 persons in the United States will die from a heart-related condition in 2021, accounting for one out of every four deaths in the country. Increased demand for heparin has resulted from a growth in the number of individuals suffering from cardiovascular problems, moving the market landscape forward. Furthermore, the increased prevalence of chronic diseases among middle-aged and elderly people will accelerate market projections.
April 21, 2021: Fresenius Kabi Introduces Low Concentration Heparin Sodium in Sodium Chloride Injection in Ready-to-Use Freeflex® Bags--
Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex® IV bags. Fresenius Kabi Heparin Sodium in Sodium Chloride injection at a concentration of 2 USP units per mL is indicated as an anticoagulant to maintain catheter patency.
April 24, 2019: B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with attached safety needle--
B. Braun Medical Inc. announced today the launch of its Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States.
By Type, Heparin Market has been segmented into
By Applications, Heparin Market has been segmented into
The report offers an in-depth assessment of the growth and other aspects of the Heparin Market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, and Latin America.
Due to the existence of important market participants such as Pfizer and Amphastar, among others, the North American heparin market was valued at over 777.5 million in 2021. Furthermore, the rising frequency of chronic diseases in North American countries is likely to promote regional market growth. According to the Centers for Disease Control and Prevention (CDC), between 5% to 8% of the population in the United States has one of several genetic risk factors, commonly known as hereditary thrombophilia, in which a genetic flaw increases the risk of thrombosis. If a result, as the risk of thrombosis rises, so will the need for heparin, boosting the North American market.
Heparin Market highlights the potential growth opportunities in upcoming years while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects in the global market. The Global Heparin Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. This Research Study compares the markets of Pre COVID-19 and Post COVID-19 with the impact of COVID-19 on the regional economy.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 3.5% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddy’s Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa), Hepalink, Changshan Pharm, Qianhong Bio-pharma, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma, Deebio |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 122 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Heparin Market?
The Heparin Market is growing at a CAGR of 3.5% over the next 5 years.
Who are the key players in Heparin Market?
Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddy’s Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa), Hepalink, Changshan Pharm, Qianhong Bio-pharma, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma, Deebio
What are the significant types of Heparin Market?
Heparin Sodium, Heparin Calcium, Other
What are the major end-use applications of Heparin Market?
UFH, LMWH
On the basis of application, Which segment is likely to hold the major share in the Heparin Market?
LMWH segment to hold the largest share in Heparin market
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.